How long should one abstain from sexual intercourse after receiving the bivalent HPV vaccine?
After receiving the bivalent HPV vaccine, if no adverse symptoms occur, it is generally safe to have sexual intercourse. However, if any physical discomfort arises, sexual activity should be avoided until the symptoms resolve.
The bivalent HPV vaccine helps prevent infections caused by human papillomavirus (HPV) types 16 and 18. It is primarily designed to protect against these two high-risk HPV types and is suitable for females aged 9 to 45. The vaccination schedule consists of three doses administered over six months, offering optimal protection when completed. Under normal circumstances, receiving the bivalent HPV vaccine does not interfere with sexual activity. If there are no post-vaccination side effects, having sex in moderation is acceptable and will not affect the vaccine's efficacy or cause harm to the body. However, if adverse reactions such as fever, fatigue, or pain, redness, and swelling at the injection site occur, sexual intercourse should be postponed until symptoms subside, as sexual activity may exacerbate discomfort and hinder recovery.
It is important to note that protective measures should be taken during sexual intercourse, and unsafe sexual practices should be avoided to reduce the risk of HPV infection.